MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, an esteemed journal published by Taylor & Francis Ltd, stands at the forefront of surgical innovation. With an ISSN of 1364-5706 and an E-ISSN of 1365-2931, this journal has been a pivotal resource since its inception in 1991, showcasing research innovations up to the year 2024. Recognized within the Q2 category in Surgery as reported in 2023, it ranks #143 out of 551 in the Scopus database, placing it firmly within the 74th percentile, thereby highlighting its significant contribution to the field. The journal aims to bridge clinical and technological advancements, providing a platform for researchers, practitioners, and students engaged in minimally invasive techniques and allied technologies. Although it operates under a subscription model, its rigorous peer-reviewed content ensures a wealth of high-quality articles, case studies, and reviews that advance knowledge and practices in surgery. The journal not only enhances understanding but also stimulates discussion around emerging innovations, making it essential reading for those dedicated to improving patient outcomes through minimally invasive strategies.

Prosthesis is an esteemed open-access journal published by MDPI, dedicated to advancing the fields of biomedical engineering, materials science, oral surgery, and rehabilitation. Since its inception in 2019, the journal has been pivotal in disseminating high-quality research that addresses contemporary challenges in prosthetic development, design, and application. With an impressive categorization in the Q2 quartile across multiple disciplines, including a Rank of #12 in Dentistry & Oral Surgery and #26 in Medicine & Rehabilitation, Prosthesis is a vital resource for researchers, practitioners, and students aiming to enhance their knowledge and impact in these rapidly evolving fields. The journal's commitment to open access ensures that its wide array of articles, studies, and reviews are freely available to the global academic community, promoting collaboration and innovation. Based in Switzerland, at ST ALBAN-ANLAGE 66, CH-4052 BASEL, Prosthesis not only fosters scholarly exchange but also aims to contribute significantly to the improvement of patient outcomes through cutting-edge research and technological advancements.

BME Frontiers, published by the American Association for the Advancement of Science, is an innovative open-access journal dedicated to the burgeoning field of Biomedical Engineering. Since its establishment in 2020, this journal has aimed to bridge the gap between cutting-edge research and practical application, promoting advancements in biomedical technologies, medical devices, and healthcare solutions. Boasting impressive rankings within Scopus—64th among 398 in Medicine (miscellaneous) and 81st among 303 in Biomedical Engineering—BME Frontiers stands out as a significant contributor to scholarly communication, offering rich insights for researchers, professionals, and students alike. With consistent publication projected through 2024, the journal serves as an essential platform for disseminating high-quality research that can drive innovation and inspire new approaches in the healthcare sector.

Global Journal of Medical Pharmaceutical and Biomedical Update, published by SCIENTIFIC SCHOLAR LLC, is a premier platform dedicated to advancing knowledge in the fields of medicine, pharmaceuticals, and biomedical sciences. With an E-ISSN of 2765-8910, this journal aims to foster innovative research and insightful discussions by providing open access to high-quality peer-reviewed articles. It serves as an invaluable resource for researchers, professionals, and students alike, ensuring that the latest advancements, methodologies, and findings are accessible to a diverse audience. Located at 50, Woodgreen Dr, Pittsford, NY 14534, the journal prioritizes the dissemination of critical information that addresses the evolving challenges faced in healthcare and biomedical research, ultimately contributing to the betterment of global health outcomes.

IRBM, published by Elsevier Science Inc, stands at the forefront of research in the domains of Biomedical Engineering and Biophysics, boasting impressively high rankings with a Q1 category in both fields according to the 2023 evaluations. With an effective focus on cutting-edge innovations and methodologies, IRBM provides a vital platform for researchers, professionals, and students alike seeking to disseminate and access groundbreaking findings and developments. Its strong presence in the Scopus database, with ranks of #12 in Biochemistry, Genetics and Molecular Biology and #42 in Biomedical Engineering, places it in the top percentile of impactful journals in the field, making it a crucial resource for advancing knowledge and fostering collaboration. While the journal maintains a traditional subscription model, it continues to attract a diverse readership eager for insightful studies and reviews that push the boundaries of science and engineering. With a projected convergence of years extending to 2024, IRBM promises to remain a significant contributor to the ongoing dialogue in the life sciences.

Tzu Chi Medical Journal, published by Wolters Kluwer Medknow Publications, is a prominent open-access journal that has been serving the medical community since its inception in 1997. With an ISSN of 1016-3190 and an E-ISSN of 2223-8956, this journal is dedicated to disseminating valuable research across various domains of medicine, achieving a prestigious Q3 ranking in the Medicine (miscellaneous) category for 2023. Operating under an open-access model since 2017, it ensures that research is freely accessible to a global audience, fostering collaboration and innovation in healthcare. Tzu Chi Medical Journal is recognized for its quality contributions, ranked #152 out of 636 in the general medicine category on Scopus, placing it in the top 25% of journals in this field. Based in Mumbai, India, it serves as an essential platform for researchers, healthcare professionals, and students aiming to share and engage with groundbreaking work in medicine, thus driving the field forward.

REVISTA CLINICA ESPANOLA, a leading journal in the field of general medicine, has been a pivotal platform for disseminating clinical research and advancements since its inception in 1947. Published by EDICIONES DOYMA S A in Barcelona, Spain, this journal plays a significant role in enhancing medical practice and research, as evidenced by its impressive Scopus ranking of #116 out of 636 in the field, placing it in the 81st percentile. Although it currently does not offer open access options, the journal continues to attract high-quality submissions focused on diverse medical topics, making it an essential resource for health professionals, researchers, and students alike. With a current categorization of Q3 in Medicine (miscellaneous), REVISTA CLINICA ESPANOLA remains committed to bridging the gap between clinical practice and research, thereby contributing to the overall improvement of healthcare outcomes.

Photobiomodulation Photomedicine and Laser Surgery is a premier peer-reviewed journal published by MARY ANN LIEBERT, INC, dedicated to advancing the understanding of light-based therapies in biomedical applications. With an impressive impact factor, this journal occupies a significant position in the field of Biomedical Engineering and Radiology, Nuclear Medicine and Imaging, evidenced by its placement in the Q3 category for both fields as of 2023. The journal's scope encompasses a wide array of research topics, including but not limited to, the therapeutic effects of photobiomodulation and innovative laser surgical techniques. Researchers and practitioners alike can benefit from its open-access format, facilitating the dissemination of cutting-edge findings to a global audience. By bridging the gap between scientific inquiry and clinical application, Photobiomodulation Photomedicine and Laser Surgery plays a crucial role in fostering the integration of advanced technologies in healthcare, enhancing patient outcomes and pushing the boundaries of medical science.

The Journal of Mechanics in Medicine and Biology, published by World Scientific Publishing Co Pte Ltd, serves as a critical platform for interdisciplinary research at the intersection of engineering and biomedical sciences. With an ISSN of 0219-5194 and E-ISSN of 1793-6810, this esteemed journal has been dedicated to exploring the mechanical principles that govern biological systems since its inception in 2008. Based in Singapore, it addresses a diverse range of topics, from biomaterials to biomechanics, contributing valuable insights into the field’s evolving landscape. Although currently positioned in Q4 of Biomedical Engineering according to the 2023 category quartiles, it is poised for growth and increased visibility within the scientific community, fostering innovation and collaboration among researchers, professionals, and students alike. The journal emphasizes the importance of cutting-edge research and its practical implications, making it a vital resource for those striving to enhance the future of medical technologies and biological understanding.

The International Journal of Biomedical Engineering and Technology, published by INDERSCIENCE ENTERPRISES LTD, serves as a pivotal platform for the dissemination of innovative research in the field of biomedical engineering. This journal, with ISSN 1752-6418 and E-ISSN 1752-6426, has been a valuable resource since its inception in 2007, boasting a converged publication timeline extending to 2024. Based in the United Kingdom, the journal aims to bridge the gap between engineering and biomedical sciences, facilitating interdisciplinary collaboration. As reflected in its 2023 Scopus ranking in the Q4 quartile of Biomedical Engineering, the journal remains accessible for researchers at various stages of their careers, contributing to its significance in promoting advancements in healthcare technologies. While currently not an open-access publication, the journal remains dedicated to enriching the biomedical engineering community by presenting novel research that addresses critical challenges, ultimately aiming to improve patient outcomes and drive innovation in medical devices and therapies.